Register for information

[Deleted]

Register for updates on Afrezza:

www.mannkindcorp.com/afrezza-register-for-afrezza-updates.htm

MNKD depended on the enthusiastic comments of several diabetics at the Adcom which helped put Afrezza over the top.  Now they want them to beg for it.  Not very nice.

[liane]

avogadro - not sure what you mean.

[seanismorris]

I agree with liane.

A page like this is standard practice for a company with a product about to become available.

For example, if I was a diabetic and signed up.  All that would happen is when Afrezza became available I'd receive an email letting me know it was time to talk to my doctor regarding new treatment options (Afrezza).  

It's a courtesy email...no bagging required.

[mannmade]

With no disrespect... And I mean it please explain how is this begging? They require absolutely no information other than an email address? This is not even worthy of a marketing effort... If I were the CMO and someone told me this was part of a marketing CRM campaign to develop relationships with customers I would fire them over the lack of information and qualifying questions.  As a benign way to help people stay informed I think it is great that they would take the time to make this information available.   Have you ever tried to fill out the information to register to win a sweepstakes where the grand prize is a toaster? Three pages later... I think they are simply trying to help get the word out early with whatever information they can when they are legally able too. To me this is Mannkind being very kind... I could go on but enough said...

Last add I registered a few weeks back when it first came out just so I ensure I do not miss any information that may be relevant for my investment in Mannkind.

[ezrasfund]

I just read through the packaging and instruction manual for Afrezza via this site, and it gives a much clearer view of how Afrezza will be presented. With the blister pack and the 3 (daily) strip I think it almost looks like a card of pills, and it looks like it could easily gain wide acceptance. Take a look if you haven't already read through this. www.mannkindcorp.com/Collateral/Documents/English-US/Afrezza_MedGuide-IFU.pdf

[Deleted]

Page 12, near the top, has a typo.  It reads "Contact your healthcare provide" and should read "Contact your healthcare provider".  I don't know a good e-mail address.  If someone has a good e-mail address would you please alert them.

[Deleted]

I admit I was not too clear. After all this time to get prepared with a marketing partner, MannKind seems no closer to market after approval than it was before. Meanwhile thousands of diabetics await its arrival. I keep going back to that NYT article that I quoted earlier:



www.nytimes.com/2014/06/28/business/afrezza-a-new-inhaled-insulin-is-approved-by-fda.html?_r=0



There it was stated:

<< MannKind also has not signed up a larger pharmaceutical company to help market Afrezza, even though it has said for years that it was in discussions with potential partners.



The approval “is obviously going to help that process,” Matthew J. Pfeffer, the company’s chief financial officer, said in an interview on Friday, adding that Afrezza would not be available to patients until a partner was ready. >>

[babaoriley]

Well, here's the way I look at it, avogadro - the mechanism that is the FDA is the culprit here. They could have approved this two or three years ago, but got cowed by the guy whose last name I'd butcher if I tried to spell it. Left MNKD short of money, so there was a limit to what they could do in the meantime. Now, MNKD has a few entities interested, no doubt, and they have every right to pick the one they think best, which, incidentally, may involve more than money, it may involve the ability to bring it to the most people the fastest.

So whatever begging diabetics would do, should be directed at the FDA (which it was), certainly not at MNKD.